LY2109761, a Novel Transforming Growth Factor Receptor Type I and Type II Dual Inhibitor, as a Therapeutic Approach to Suppressing Pancreatic Cancer Metastasis
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-0337
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2008
Authors
Publisher
American Association for Cancer Research (AACR)